Market Research Report
Europe Cosmetic Surgery and Procedure Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||577314|
|Published||Content info||81 Pages
Delivery time: 2-3 business days
|Europe Cosmetic Surgery and Procedure Market Forecast 2019-2027|
|Published: March 4, 2019||Content info: 81 Pages||
The Europe cosmetic surgery and procedures market collected a revenue of $XX million in 2018. The market is expected to rise with the second highest CAGR of 5.78% over the forecast period of 2019-2027. The European region collected the second-highest revenue in the global market in the year 2016.
The growing demand for noninvasive procedures from Western Europe and increasing interest from Eastern Europe are the major key factors that are expected to drive the European cosmetic surgery and procedure market. Also, most of the women population in European countries consider cosmetic surgery as a necessity rather than a luxury. This factor is considerably propelling the European countries such as Germany, France, the United Kingdom, Italy, Spain and Rest of Europe into the spotlight.
The German market collected the highest revenue in the year 2018. However, it is the United Kingdom market that is expected to prosper with the highest CAGR over the forecast period. The increased openness from celebrities about the cosmetic work that they have undergone has contributed to fewer reservations about nip and tucks in the U.K. Laser depilation, botox treatments, reabsorbing fillers, and lip retouching are some of the cosmetic procedures that are gaining popularity amongst the male European population.
Some of the top players in this market include Lumenis, Depuy Synthes Companies, Cutera, IPSEN, Merz Pharma, Nestle, Galderma, Cynosure, Inc., Syneron Medical, Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), Alma Lasers Inc., Johnson & Johnson, Sientra Inc., Sinclair Pharma, and Allergan PLC.